Airbnb, Royal Caribbean Cruises, and Carnival are the three Leisure stocks to watch today, according to MarketBeat’s stock screener tool. Leisure stocks are shares of companies whose primary businesses provide recreational, travel, entertainment and hospitality services—such as airlines, hotels, cruise lines, casinos, theme parks, restaurants and other consumer-facing entertainment firms. They are typically cyclical and sensitive to consumer discretionary spending, seasonality and economic conditions, making them attractive for growth and recovery plays but often more volatile in downturns. These companies had the highest dollar trading volume of any Leisure stocks within the last several days.
Airbnb (ABNB)
Airbnb, Inc., together with its subsidiaries, operates a platform that enables hosts to offer stays and experiences to guests worldwide. The company’s marketplace connects hosts and guests online or through mobile devices to book spaces and experiences. It primarily offers private rooms, primary homes, and vacation homes.
Royal Caribbean Cruises (RCL)
Royal Caribbean Cruises Ltd. operates as a cruise company worldwide. The company operates cruises under the Royal Caribbean International, Celebrity Cruises, and Silversea Cruises brands, which comprise a range of itineraries. As of February 21, 2024, it operated 65 ships. Royal Caribbean Cruises Ltd.
Read Our Latest Research Report on RCL
Carnival (CCL)
Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America and Australia (NAA) Cruise, Europe and Asia (EA) Cruise Operations, Cruise Support, and Tour and Others. The North America and Australia (NAA) Cruise segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn.
Read Our Latest Research Report on CCL
Further Reading
- MarketBeat’s Top Five Stocks to Own in October 2025
- Bloom Energy’s Game-Changing AI Deal: Why the Rally Has Legs
- Intel’s Turnaround Hits Hyperspeed With A New 52-Week High
- Oracle’s AI Profits Look Slim—Are NBIS and CRWV at Risk Too?
- Abbott Laboratories’ October Price Plunge Is a Signal to Buy
- Why Wells Fargo’s Turnaround Just Hit High Gear